The Translational PET Imaging lab is applying in vivo molecular imaging techniques, e.g. Positron Emission Tomography (PET), for advancement of our understanding and management of different pathologies, in particular metabolic disease and cancer.
My current main research interests are:
I) non-invasive imaging methodologies for assessment of beta cell-mass in diabetes,
II) imaging markers for activated T-cells, for use in immuno-oncology and in the many diseases where inflammation is an important feature,
III) assisting drug development, by design of novel imaging-based endpoints (e.g. in vivo mode of action, drug biodistribution),
IV) translational research, i.e. bringing radiopharmaceuticals from design and radiolabeling, via preclinical evaluation, to clinical proof-of-concept.
Bibliometric data January 2020: >65 publications, h-index = 22. Invited speaker at >20 international congresses.
Olof Eriksson, Associate Senior Lecturer, SciLifeLab Fellow
Emmi Puuvuori, Ph.D. student
Maria Rosestedt, Postdoc
Bo Zhang, Postdoc
Pierre Cheung, Ph.D. student
Irina Velikyan, Researcher